Offices in Chicago and Milwaukee

 
     
 

ADVAIR & SEREVENT

On August 14, 2003, the FDA released warnings for GlaxoSmithKline drugs Advair and Serevent, both of which contained containing salmeterol, a bronchodilator used to treat asthma and emphysema.

This warning was based on a 28 week study that showed a significantly higher risk of life-threatening asthma attacks or asthma-related deaths when taking Serevent.

*Click here* to contact our firm about a potential case!

Disclaimer of legal advice: Nothing on this website should be construed as legal advise. Past performance does not necessarily guarantee similar results.